RIGL
Rigel Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -12.5% ·
share flow +9.9% ·
net new positions -14.3%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | -2 | 9.47M | $370.29M | +3 | −5 |
| Q1 2026 | 77 | -10 | 11.13M | $301.00M | — | −10 |
| Q4 2025 | 86 | +1 | 11.49M | $491.92M | +1 | — |
| Q3 2025 | 18 | +3 | 6.87M | $194.53M | +3 | — |
| Q2 2025 | 12 | +2 | 4.47M | $83.70M | +2 | — |
| Q1 2025 | 7 | -1 | 1.55M | $27.81M | +2 | −3 |
| Q4 2024 | 8 | +4 | 1.41M | $23.66M | +5 | −1 |
| Q3 2024 | 3 | -2 | 554.02K | $8.97M | — | −2 |
| Q2 2024 | 5 | — | 605.71K | $4.98M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 637.03K | +67.4% | $11.46M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 411.17K | +2.3% | $7.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 411.17K | +2.3% | $7.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Marshall Wace ✦ | 211.75K | New | $3.81M | 0.0% | New | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 211.75K | New | $3.81M | 0.0% | New | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 201.15K | -32.9% | $3.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 61.40K | +75.5% | $1.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 61.40K | +75.5% | $1.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 12.68K | -79.2% | $228,077 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 10.63K | New | $191,162 | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 10.63K | New | $191,162 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 10.63K | New | $191,162 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 10.63K | New | $191,162 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 10.63K | New | $191,162 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $3.81M | 0.0% |
| Marshall Wace | $3.81M | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
| AQR Capital Management | $191,162 | 0.0% |
Exited
| Norges Bank | $2.18M | was 0.0% |
| Millennium Management | $1.18M | was 0.0% |
| Citadel Advisors | $477,873 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 146 holders, 15.81M shares, $391.97M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.